Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Tetracyclines and Pulmonary Inflammation

Volume:7   Issue: 4
Pp: 232-236
S. Rempe, J. M. Hayden, R. A. Robbins and J. C. Hoyt
DOI: 10.2174/187153007782794344

Protein Structure Based Strategies for Antigen Discovery and Vaccine Development Against Malaria and Other Pathogens

Volume:7   Issue: 4
Pp: 259-265
Giampietro Corradin, Viviane Villard and Andrey V. Kajava
DOI: 10.2174/187153007782794371

Controlled-release Particulate Cytokine Adjuvants for Cancer Therapy

Volume:7   Issue: 4
Pp: 266-270
Nejat K. Egilmez, Mehmet O. Kilinc, Tao Gu and Thomas F. Conway
DOI: 10.2174/187153007782794335

Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut

Volume:7   Issue: 4
Pp: 288-291
Daniele Fina, Roberta Caruso, Francesco Pallone and Giovanni Monteleone
DOI: 10.2174/187153007782794308

Evidence for the Role of Luteinizing Hormone in Alzheimer Disease

Volume:7   Issue: 4
Pp: 300-303
Kate M. Webber, Gemma Casadesus, Richard L. Bowen, George Perry and Mark A. Smith
DOI: 10.2174/187153007782794326